Texas officials are cracking down on abortion pill shipments into the state, warning health care providers they could face heavy fines and legal action if they continue. Attorney General Ken Paxton’s office recently sent letters to three providers, including a California doctor and a Delaware clinic, saying they have evidence these groups sent medication that ends pregnancies to Texas residents. Each violation could lead to a $100,000 penalty.
The letters dated August 14 threaten formal investigations and lawsuits if the providers don’t stop, specifically calling out Debra Lynch, a nurse practitioner who runs the women’s health clinic Her Safe Harbor. Lynch, who has openly spoken about sending pills to Texas women, said she isn’t afraid of the warnings and will keep sending the medication. She stressed that women’s safety is her priority, even as she advises caution around online orders to avoid leaving digital evidence.
This move from Texas is part of a broader effort by anti-abortion groups and lawmakers to limit access to the pill mifepristone across the U.S. In 2025 alone, dozens of bills have been introduced in various states to ban or restrict medication abortions—more than any year since the Supreme Court overturned Roe v. Wade in 2022. Meanwhile, large retailers like Costco have stopped selling abortion pills, citing little customer demand but also facing pressure from religious groups.
The Texas letters referenced a civil lawsuit against California doctor Rémy Coeytaux. A man filed the suit claiming his girlfriend broke state laws by using abortion pills purchased from Coeytaux, supported by a Venmo transaction for the medication. Coeytaux has not commented on the matter.
Lynch acknowledges the legal threats but encourages women not to be scared. Texas law targets those who provide abortion pills, not the women who take them. Her clinic plans to continue providing safe access to medication abortions no matter the obstacles, committed to supporting those who need care.
This enforcement effort highlights the growing battle over abortion rights and access to medication in the U.S., as states take different paths on how to handle abortion providers and patients in the post-Roe era.